NMTRQ — 9 Meters Biopharma Cashflow Statement
0.000.00%
Last trade - 00:00- $0.00m
- -$1.87m
Annual cashflow statement for 9 Meters Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -24.2 | -27 | -61.5 | -36.8 | -43.8 |
| Depreciation | |||||
| Non-Cash Items | 9.63 | 5.16 | 41.3 | 5.06 | 5.85 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.653 | 3.89 | 0.775 | 2.23 | 0.661 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -15.2 | -18 | -19.4 | -29.5 | -37.2 |
| Capital Expenditures | -0.014 | -0.012 | -0.003 | -0.012 | -0.003 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0 | -3.18 | -2.42 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.014 | -0.012 | -3.19 | -2.43 | -0.003 |
| Financing Cash Flow Items | -0.26 | -1.1 | -6.42 | -2.9 | -1.09 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 20.6 | 16.8 | 55.9 | 41.1 | 19.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.37 | -1.14 | 33.3 | 9.14 | -17.3 |